Medicare Enrolled
Dr. Mehnaz Junagadhwalla, MD
Hematology · Englewood, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Junagadhwalla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Junagadhwalla? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Junagadhwalla
Dr. Mehnaz Junagadhwalla is a hematology in Englewood, FL, with 18 years in practice. Based on federal Medicare data, Dr. Junagadhwalla performed 187,273 Medicare services across 5,733 unique beneficiaries.
Between the years covered by Open Payments, Dr. Junagadhwalla received a total of $10,382 from 70 pharmaceutical and/or device companies across 527 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Junagadhwalla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 23% volume in FL$ $10,382 industry payments
Medicare Practice Summary
Medicare Utilization ↗187,273
Medicare services
Top 23% in FL for hematology
5,733
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,404 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 24,631 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 24,540 | $0 | $2 |
| Iron infusion (Feraheme) | 20,400 | $0 | $4 |
| Filgrastim injection (Nivestym) for white blood cells | 18,660 | $0 | $1 |
| Oxaliplatin chemotherapy injection | 17,700 | $0 | $12 |
| Anti-nausea injection (aprepitant) | 16,770 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 11,400 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 10,260 | $19 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 7,801 | $6 | $23 |
| Paclitaxel chemotherapy injection | 6,494 | $0 | $2 |
| Iron infusion (Monoferric) | 4,200 | $16 | $57 |
| Complete blood count (CBC) with differential | 2,972 | $8 | $29 |
| Blood draw (venipuncture) | 2,856 | $8 | $9 |
| Injection, eflapegrastim-xnst, 0.1 mg | 2,772 | $26 | $116 |
| Dexamethasone injection (steroid) | 2,576 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,580 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,564 | $95 | $339 |
| Injection, leucovorin calcium, per 50 mg | 1,278 | $3 | $12 |
| Drug injection, under skin or into muscle | 997 | $10 | $69 |
| Injection, fluorouracil, 500 mg | 882 | $2 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 491 | $98 | $378 |
| Injection of additional new drug or substance into vein | 475 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 468 | $0 | $9 |
| Injection, magnesium sulfate, per 500 mg | 466 | $1 | $2 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 430 | $22 | $84 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 378 | $1 | $6 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 315 | $17 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 310 | $48 | $189 |
| Office visit, established patient (20-29 min) | 303 | $65 | $239 |
| Injection, carboplatin, 50 mg | 284 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 253 | $15 | $56 |
| Ct scan of chest with contrast | 248 | $54 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 185 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 175 | $21 | $79 |
| CT scan of abdomen and pelvis with contrast | 152 | $172 | $550 |
| Infusion into a vein for hydration, each additional hour | 134 | $10 | $42 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 134 | $401 | $680 |
| Administration of additional new drug or substance into vein, 1 hour or less | 131 | $49 | $178 |
| New patient office visit, complex (60-74 min) | 113 | $159 | $585 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 109 | $1,097 | $3,706 |
| Office visit, established patient, complex (40-54 min) | 106 | $135 | $474 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 106 | $127 | $637 |
| Infusion, normal saline solution , 1000 cc | 93 | $2 | $7 |
| Automated urinalysis | 92 | $2 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 91 | $25 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 88 | $15 | $56 |
| Red blood count, automated test | 79 | $4 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 68 | $132 | $562 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 63 | $53 | $206 |
| Administration of additional new drug or substance into vein using push technique | 63 | $42 | $170 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $25 | $89 |
| New patient office visit (45-59 min) | 53 | $122 | $453 |
| CT scan of chest, without contrast | 44 | $45 | $350 |
| Prothrombin time test (blood clotting) | 43 | $4 | $15 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 43 | $1 | $7 |
| Hospital follow-up visit, moderate complexity | 39 | $63 | $197 |
| Injection of drug or substance into vein | 38 | $28 | $156 |
| Ct scan of abdomen and pelvis before and after contrast | 36 | $197 | $708 |
| Nuclear medicine study whole body with ct scan | 31 | $1,098 | $3,706 |
| Initial hospital admission, high complexity | 30 | $137 | $556 |
| Ct scan of abdomen and pelvis without contrast | 26 | $78 | $391 |
| Drawing of blood for a medical problem | 26 | $68 | $277 |
| Ct scan of soft tissue of neck with contrast | 22 | $71 | $704 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 20 | $102 | $467 |
| Hospital follow-up visit, high complexity | 19 | $94 | $285 |
| Red blood count automated, with additional calculations | 12 | $5 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.0% high complexity
81.2% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,382
Total received (2018-2024)
Avg $1,483/year across 7 years
Top 41% in FL for hematology
70
Companies
527
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,026 (96.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$356 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,406
2023$2,426
2022$2,174
2021$681
2020$269
2019$1,278
2018$1,147
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$797
E.R. Squibb & Sons, L.L.C.
$677
PFIZER INC.
$660
Genentech USA, Inc.
$627
Celgene Corporation
$529
Merck Sharp & Dohme LLC
$436
Daiichi Sankyo Inc.
$412
Incyte Corporation
$388
BeiGene USA, Inc.
$383
Lilly USA, LLC
$345
Astellas Pharma US Inc
$326
Gilead Sciences, Inc.
$305
Janssen Biotech, Inc.
$302
Amgen Inc.
$289
Regeneron Healthcare Solutions, Inc.
$258
Seagen Inc.
$256
GENZYME CORPORATION
$251
Merck Sharp & Dohme Corporation
$234
Bayer Healthcare Pharmaceuticals Inc.
$173
AstraZeneca Pharmaceuticals LP
$157
JAZZ PHARMACEUTICALS INC.
$146
EMD Serono, Inc.
$136
Exelixis Inc.
$131
Acrotech Biopharma Inc.
$125
Kite Pharma, Inc.
$115
GlaxoSmithKline, LLC.
$103
Ipsen Biopharmaceuticals, Inc
$102
Takeda Pharmaceuticals U.S.A., Inc.
$91
ARRAY BIOPHARMA INC
$90
Mirati Therapeutics, Inc.
$81
ADC Therapeutics America, Inc.
$80
Bayer HealthCare Pharmaceuticals Inc.
$75
ABBVIE INC.
$74
Sumitomo Pharma America, Inc.
$72
Eisai Inc.
$68
Pharmacyclics LLC, An AbbVie Company
$63
AVEO Pharmaceuticals, Inc.
$54
TAIHO ONCOLOGY, INC.
$51
Genentech, Inc.
$50
RECORDATI_RARE_DISEASES_INC.
$47
Pharmacyclics LLC, an AbbVie Company
$46
Puma Biotechnology, Inc.
$46
Heron Therapeutics, Inc.
$44
Rigel Pharmaceuticals, Inc.
$42
PharmaEssentia USA Corporation
$42
Deciphera Pharmaceuticals Inc.
$42
Dendreon Pharmaceuticals LLC
$40
Blueprint Medicines Corporation
$34
Karyopharm Therapeutics Inc.
$33
Aveo Pharmaceuticals, Inc.
$33
AbbVie, Inc.
$32
Legend Biotech USA Inc.
$31
INSYS Therapeutics Inc
$29
Clovis Oncology, Inc.
$28
Stemline Therapeutics Inc.
$26
SERVIER PHARMACEUTICALS LLC
$25
PUMA BIOTECHNOLOGY, INC.
$25
Alnylam Pharmaceuticals Inc.
$22
Shire North American Group Inc
$21
SOBI, INC
$20
Janssen Pharmaceuticals, Inc
$20
G1 Therapeutics, Inc.
$19
GE HealthCare
$19
Agios Pharmaceuticals, Inc.
$18
Dova Pharmaceuticals
$17
CTI BioPharma Corp.
$15
Spectrum Pharmaceuticals Inc.
$15
Myovant Sciences Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
Array BioPharma Inc.
$13
Top 3 companies account for 20.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENLYSTA · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · Enhertu · Erleada · FASENRA · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · HYQVIA · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SUSTOL · SUTENT · SYLVANT · SYNDROS · Stivarga · TABRECTA · TASIGNA · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
16
Per 100K population
3.6
County median income
$80,633
Nearest hospital
HCA FLORIDA ENGLEWOOD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Junagadhwalla is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Junagadhwalla experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Junagadhwalla performed 24,631 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Junagadhwalla receive payments from pharmaceutical companies?
Yes. Dr. Junagadhwalla received a total of $10,382 from 70 companies across 527 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Junagadhwalla's costs compare to other hematologys in Englewood?
Dr. Junagadhwalla's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Junagadhwalla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Englewood
Browse hematologys in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology